HORIZON

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy

Topic / Pathology

  • Multiple System Atrophy (MSA)

Objectives

To have more informations, click on the link below:

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON) - Full Text View - ClinicalTrials.gov

Sponsor

Ionis Pharmaceuticals

Status

Recruitment completed

Participating centers

Share

Updated on 05 August 2025